CLASS II ONGOING Device recall · Reported 9 Oct 2024 · FDA Enforcement Report

Advia Centaur aTPO Assay, Material Number recalled

Siemens Healthcare Diagnostics is recalling Advia Centaur aTPO Assay, Material Number 10630886 (100 Test) and 10630887 (500 Test), distributed nationwide in the US. The recall was initiated on 21 Aug 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: Material Number 10630886 (100 Test) - 00630414587837; Material Number 10630887 (500 Test) - 00630414587844; Lot Number: 26053337 26054337 26051337 26052337
Quantity recalled5622 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3304-2024
FDA event ID
95259
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Ongoing
Recall initiated
21 Aug 2024
FDA classified
27 Sep 2024
Reported
9 Oct 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

21 Aug 2024Recall initiated by company
27 Sep 2024Classified by FDA+37 days
9 Oct 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the Atellica IM analyzer.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

ADVIA Centaur aTPO Assay, Material Number 10630886 (100 Test) and 10630887 (500 Test)

Where it was distributed

Worldwide distribution - US Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the Atellica IM analyzer.

Which lots are affected?

UDI-DI: Material Number 10630886 (100 Test) - 00630414587837; Material Number 10630887 (500 Test) - 00630414587844; Lot Number: 26053337 26054337 26051337 26052337

Where was it sold?

Worldwide distribution - US Nationwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 95259

This product is part of a recall event; the main page for the event is Atellica IM aTPO Assay, Material Number recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIAtellica IM aTPO Assay, Material Number recalledSiemens Healthcare DiagnosticsPotency & AssayNationwide

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656